Advertisement
Screener

ImmuCell Corporation (ICCC) Debt / Equity

ImmuCell Corporation (ICCC) Debt / Equity

  • 2026-06-30: Debt/Equity Ratio 0.26.
  • 2026-03-31: Debt/Equity Ratio 0.3.
  • 2025-12-31: Debt/Equity Ratio 0.34.
  • 2025-09-30: Debt/Equity Ratio 0.32.

Complete source-backed debt/equity ratio history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2026-06-300.26
2026-03-310.3
2025-12-310.34
2025-09-300.32
2025-06-300.33
2024-12-310.38
2022-12-310.63
2020-09-300.69
2020-06-300.7
2020-03-310.59
2019-12-310.58
2019-09-300.6
2019-06-300.6
2019-03-310.6
2018-12-310.86
2018-09-300.84
2018-06-300.8
2018-03-310.79
2017-12-310.76

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-310.34
2024-12-310.38
2022-12-310.63
2019-12-310.58
2018-12-310.86
2017-12-310.76

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92